Industry Sponsors and Exhibitors
Amgen
Amgen, a leading player in biotechnological research for forty years, is among the world leaders in innovation in some of the major therapeutic areas such as cardiovascular, osteoarticular diseases, inflammatory diseases, nephrology and oncology and haematology. In these areas, it is able to develop cutting-edge solutions, based on the integration of genetics, cell biology and molecular engineering, including monoclonal antibodies, multispecific drugs and cell therapies. Through its commitment to biosimilars, Amgen plays an important role in providing patients with wider access to innovative medicines, contributing to the sustainability of the healthcare system.
Angelini Pharma
Angelini Pharma is the pharmaceutical division of Angelini Group. The Group started almost 100 years ago as a small pharmaceutical laboratory, and over the years has grown into a leading international group in healthcare, present in Pharmaceuticals and Mass-Market.
Angelini Pharma is a leader in healthcare, with particular strength and expertise in the fields of Mental Health, including Pain, and Rare Diseases through its new Angelini Pharma Rare Diseases AG Business Unit dedicated to develop, manufacture and commercialize gaboxadol for the potential treatment of Angelman syndrome in Europe. The company is also a leading player in the Consumer Health segment, with highly successful OTC brands in Italy and abroad.
Angelini products are marketed in about 70 countries. The company operates directly in 15 countries employing more than 2.700 people, and commercializes its products in more than 50 countries through strategic alliances with leading international pharmaceutical groups.
Convatec Infusion Care
Convatec Infusion Care is a leading manufacturer of infusion sets. Since the 1980’s the company has sold millions of infusion sets worldwide every year for use with continuous subcutaneous drug delivery. Convatec Infusion care is a franchise of ConvaTec and located in Denmark.
Our neria™ infusion sets have been drug compatibility tested with drugs for the following diseases; Pain Management, Parkinson’s Disease, Thalassemia and Primary Immune Deficiency. Our success is based on a high degree of innovation supported by user-friendliness and superior quality. All over the world users benefit from the Convatec infusion sets improving their quality of life and treatment options. Please visit www.neria.com for more information on the neria™ infusion set product line, including instruction videos and brochure materials.
Grünenthal
Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We’re driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs. We are focussing all of our activities and efforts on moving towards our vision of a world free of pain.
Helixor Heilmittel GmbH
Helixor Heilmittel GmbH is a German pharmaceutical company focused and committed to one mission: improving the quality of life of cancer patients. We do that by manufacturing and distributing medicinal products from extracts of mistletoe (Viscum album) and two species of hellebore (Helleborus niger and H. foetidus). We aim to offer cancer patients well-researched natural products to improve their quality of life, decrease side effects of conventional cancer therapies, and extend their life expectancy. We look forward to shaping a brighter future for cancer patients. Join us!
Istituto Gentili
Istituto Gentili is an Italian biopharmaceutical company with over a century of history and expertise in the development and commercialization of innovative molecules – both of its own and made in partnership.
Kyowa Kirin
Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the-art antibody technologies, in the core therapeutic areas of oncology, nephrology, central nervous system and immunology.
MedicinesComplete
MedicinesComplete makes it easy for healthcare professionals to access essential medicines information at the point of care. Trusted evidence-based resources include British National Formulary, Stockley’s Drug Interactions, Martindale: The Complete Drug Reference, Palliative Care Formulary and many more specialist resources. Our skilled editorial team of clinical writers includes pharmacists and science graduates who triage new information, assess evidence and review changes made by other clinical writers before publication. Certain content is further assessed by external experts, committee and peer review. Ensuring clear, concise and actionable guidance to support confident decision-making on the use and administration of drugs and medicines, and effective patient care.
MedicinesComplete is a Pharmaceutical Press product from The Royal Pharmaceutical Society.
Palliative Medicine is a highly ranked, peer reviewed scholarly journal which publishes primarily original research and systematically constructed reviews. Other paper types include regular editorials to contextualise and direct the research we publish, case reports to highlight clinical issues where research attention is required, and service evaluations where they are of the highest quality.
People interested in the journal can see the papers we publish here, and find out about how to submit a paper here. Palliative Medicine works hard to make the papers it publishes accessible and relevant. Each year the journal has a call for papers for a special issue on an area of topic interest. Each year the journal also awards a prize to the best paper published in the previous year’s print issues, awarded at the EAPC congress.
Journal of Palliative Medicine is the premier peer-reviewed journal covering medical, psychosocial, policy, and legal issues in end-of-life care and relief of suffering for patients with intractable pain. The Journal presents essential information for professionals in hospice/palliative medicine, focusing on improving quality of life for patients and their families, and the latest developments in drug and non-drug treatments. Journal coverage includes:
- The latest medical advances in pain and symptom management
- Evidence-based protocols
- Model palliative care programs
- Clinical case reports
- Guidance for working with patients and their families
- Psychological and spiritual aspects of end-of-life care
- Roundtable discussions with leading experts in the field
Full details on the Journal, Editorial Board, the latest issues and articles online ahead-of-print, and details on how to publish in the Journal, please visit the Journal website.
Visit our congress stand
Not for Profit Exhibitors
Academic Organisation Exhibitors
